The Maintenance Treatment of "ITIVA" in AML Patients
Conditions
Acute Myeloid Leukemia · Maintenance Treatment · Minor Residue Disease · Interferon-α-1b · Interleukin-2 · Thalidomide · Venentoclax · Azacitidine
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan, China
Study leads
Xudong None Wei, Doctor/Professor
Principal Investigator
Cancer Hospital of Henan Province